Related Experiment Video
Updated: Aug 24, 2026

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes
Published on: May 25, 2022
Phospholipase C gene expression, protein content, and activities in cardiac hypertrophy and heart failure due to
Melissa R Dent1, Naranjan S Dhalla, Paramjit S Tappia
1Department of Physiology, Faculty of Medicine, St Boniface General Hospital Research Centre University of Manitoba, Winnipeg, Manitoba R2H 2A6, Canada.
Insights
Volume overload from arteriovenous shunts causes cardiac hypertrophy and heart failure. Phosphoinositide phospholipase C (PLC) isozyme activity changes, impacting cardiac function during these conditions.
Area of Science:
- Cardiovascular Physiology
- Molecular Cardiology
- Biochemistry
Background:
- Volume overload from arteriovenous (AV) shunts induces cardiac hypertrophy and can progress to heart failure.
- Phosphoinositide phospholipase C (PLC) enzymes play a role in cardiac function by metabolizing phosphatidylinositol 4,5-bisphosphate (PIP(2)).
Purpose of the Study:
- To investigate the dynamic changes in diacylglycerol (DAG) and inositol (1,4,5)-trisphosphate (IP(3)) levels.
- To analyze the time-course of alterations in phosphoinositide phospholipase C (PLC) isozyme gene expression, protein content, and enzymatic activity.
- To correlate these molecular changes with cardiac hypertrophy and heart failure induced by AV shunt in a rat model.
Main Methods:
- Induction of volume overload using an AV shunt in Sprague-Dawley rats.
- Measurement of left ventricle (LV)-to-body weight ratio to confirm cardiac hypertrophy.
- Quantification of PLC isozyme (beta(1), gamma(1), delta(1)) mRNA, protein levels, and enzymatic activities at various time points.
- Assessment of sarcolemmal (SL) PIP(2) content.
Main Results:
- Cardiac hypertrophy was confirmed by increased LV-to-body weight ratio at 4 weeks.
- PLC-beta(1) activity, mRNA, and protein increased early (3 days to 2 weeks) but normalized by 4 weeks, then increased again at later time points (8-16 weeks).
- PLC-gamma(1) activity, mRNA, and protein increased at 3 days and 4 weeks, while PLC-delta(1) activity, gene expression, and protein decreased progressively from 1 to 4 weeks, with further depression at 8-16 weeks.
- Sarcolemmal PIP(2) content progressively decreased during hypertrophy and heart failure.
Conclusions:
- Phosphoinositide phospholipase C (PLC) isozyme signaling is upregulated during the development of cardiac hypertrophy.
- PLC isozyme signaling is altered, with decreased activity of certain isoforms, in the progression to heart failure due to volume overload.
- These findings highlight the complex role of PLC isozymes in the pathophysiology of pressure overload-induced cardiac remodeling and dysfunction.
Abstract:
Volume overload due to arteriovenous (AV) shunt results in cardiac hypertrophy followed by the progression to heart failure. The phosphoinositide phospholipase C (PLC) converts phosphatidylinositol 4,5-bisphosphate (PIP(2)) to 1,2-diacylglycerol (DAG) and inositol (1,4,5)-trisphosphate (IP(3)), which are known to influence cardiac function. Therefore, we examined the time course of changes in DAG and IP(3) as well as PLC isozyme gene expression, protein content, and activities in cardiac hypertrophy and heart failure induced by AV shunt in Sprague-Dawley rats by the needle technique. An increase in the left ventricle (LV)-to-body weight ratio demonstrated that LV hypertrophy was established at 4 wk after the induction of the shunt. PLC-beta(1) activity was increased two- and sevenfold at 3 days and 1 and 2 wk after the induction of volume overload, respectively. These changes were associated with increases in the mRNA and sarcolemmal (SL) protein content; however, no changes in PLC-beta(1) were detected at 4 wk. On the other hand, a significant increase in PLC-gamma(1) activity as well as mRNA and SL protein was seen at 3 days and 4 wk. A progressive decrease in PLC-delta(1) activity with concomitant reductions in the gene expression and SL protein abundance was detected during 1 to 4 wk. Activity of gamma(1)- and delta(1)-isozymes was significantly depressed during the 8- and 16-wk time points, whereas beta(1)-isozyme was increased significantly during these time points. A progressive decrease in the SL PIP(2) content was observed during cardiac hypertrophy and heart failure. Our findings indicate that PLC isozyme signaling processes are increased in hypertrophy and decreased in heart failure due to volume overload.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Cellular Adaptation II: Hypertrophy
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Cell Specific Gene Expression
Pathophysiology of Cardiac Performance
